UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of April 2024
Commission File No. 001-41010
MAINZ BIOMED N.V.
(Translation of registrant’s name into English)
Robert Koch Strasse 50
55129 Mainz
Germany
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F
Form 20-F ☒ Form 40-F ☐
Other Events
On or around May 16, 2024, Mainz Biomed N.V. will mail to certain shareholders pursuant to Dutch law, documents relating to its annual general meeting of shareholders to be held on May 31, 2024. Copies of certain of these documents are attached as exhibits hereto.
| Exhibit No. | Exhibit | |
| 99.1 | Announcement of Annual General Meeting | |
| 99.2 | Notice of Annual General Meeting | |
| 99.3 | Agenda of the Annual General Meeting | |
| 99.4 | Voting Proxy | |
| 99.5 | Announcement of Nominations |
1
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: April 24, 2024 | By: | /s/ William J. Caragol |
| Name: | William J. Caragol | |
| Title: | Chief Financial Officer |
2